Edition:
India

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

87.64USD
9:19pm IST
Change (% chg)

$0.82 (+0.94%)
Prev Close
$86.82
Open
$86.38
Day's High
$87.73
Day's Low
$86.38
Volume
50,544
Avg. Vol
318,121
52-wk High
$106.26
52-wk Low
$71.90

Latest Key Developments (Source: Significant Developments)

AmerisourceBergen Reports Fiscal Q3 Results
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN REPORTS FISCAL 2018 THIRD QUARTER RESULTS.REVENUES OF $43.1 BILLION FOR Q3, AN 11.5 PERCENT INCREASE YEAR-OVER-YEAR.Q3 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.54 EXCLUDING ITEMS.Q3 GAAP EARNINGS PER SHARE $1.25.Q3 EARNINGS PER SHARE VIEW $1.46 -- THOMSON REUTERS I/B/E/S.AMERISOURCEBERGEN - CONTINUES TO EXPECT ADJUSTED EARNINGS PER SHARE FOR FISCAL YEAR 2018 TO BE NEAR BOTTOM OF ITS GUIDANCE RANGE OF $6.45 TO $6.65.AMERISOURCEBERGEN - "AS AN UPDATE ON PHARMEDIUM, WE NOTIFIED THE FDA TWO WEEKS AGO THAT WE WERE RESUMING LIMITED PRODUCTION AT THE MEMPHIS FACILITY".AMERISOURCEBERGEN - "CONTINUE TO EXPECT PRODUCTION IN MEMPHIS TO INCREASE GRADUALLY OVER TIME AND BE FULLY OPERATIONAL IN FISCAL 2019".Q3 REVENUE VIEW $42.91 BILLION -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $6.48 -- THOMSON REUTERS I/B/E/S.  Full Article

AmerisourceBergen Reports Q2 Earnings Per Share $1.29
Wednesday, 2 May 2018 

May 2 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN REPORTS FISCAL 2018 SECOND QUARTER RESULTS.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $6.45 TO $6.65.Q2 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.94 EXCLUDING ITEMS.Q2 GAAP EARNINGS PER SHARE $1.29.Q2 EARNINGS PER SHARE VIEW $1.82 -- THOMSON REUTERS I/B/E/S.NOW BELIEVES ADJUSTED DILUTED EPS FOR FISCAL YEAR 2018 WILL BE AT BOTTOM OF ITS GUIDANCE RANGE OF $6.45 TO $6.65.SEES FISCAL YEAR 2018 REVENUE GROWTH IN RANGE OF 8 PERCENT TO 11 PERCENT ON AN ADJUSTED BASIS.REVENUES OF $41.0 BILLION FOR THE SECOND QUARTER, A 10.5 PERCENT INCREASE.Q2 REVENUE VIEW $40.64 BILLION -- THOMSON REUTERS I/B/E/S.SEES FISCAL YEAR 2018 ADJUSTED OPERATING INCOME GROWTH TO BE FLAT.FY2018 EARNINGS PER SHARE VIEW $6.53, REVENUE VIEW $167.48 BILLION -- THOMSON REUTERS I/B/E/S.AMERISOURCEBERGEN - LOWER THAN PREVIOUSLY ANTICIPATED OPERATING INCOME CONTRIBUTIONS FROM PHARMEDIUM & LASH GROUP LED TO UPDATED FY 2018 GUIDANCE.  Full Article

AmerisourceBergen Anticipates Operations At Memphis Facility Will Resume This Quarter
Tuesday, 6 Feb 2018 

Feb 6 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN CORP CFO SAYS MEMPHIS FACILITY REMAINS CLOSED AND CURRENTLY ANTICIPATE OPERATIONS WILL RESUME THIS QUARTER - CONF CALL.AMERISOURCEBERGEN CORP CFO SAYS WE WERE PREVIOUSLY OPTIMISTIC THAT MEMPHIS OPERATIONS WOULD RESTART IN EARLY JANUARY - CONF CALL.AMERISOURCEBERGEN CORP CFO SAYS SEES 2018 PHARMACEUTICAL DISTRIBUTION SERVICES REVENUE GROWTH OF 1% TO 4%, REDUCED TO REFLECT IMPACT FROM PHARMEDIUM - CONF CALL.  Full Article

AmerisourceBergen Corp Says CEO Steven Collis' FY 2017 Total Compensation Was $9.9 Mln Vs $10.0 Mln In FY 2016
Friday, 19 Jan 2018 

Jan 19 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN CORP SAYS CEO STEVEN COLLIS' FY 2017 TOTAL COMPENSATION WAS $9.9 MILLION VERSUS $10.0 MILLION IN FY 2016 - SEC FILING.  Full Article

AmerisourceBergen Announces Operating Commitments to Address Opioid Diversion And Abuse
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Amerisourcebergen Corp ::AMERISOURCEBERGEN ANNOUNCES OPERATING COMMITMENTS TO ADDRESS OPIOID DIVERSION AND ABUSE.AMERISOURCEBERGEN - WILL CONTINUE TO REPORT QUANTITY, RECEIVING PHARMACY OF ALL ORDERS OF OPIOID-BASED MEDICINES TO DRUG ENFORCEMENT AGENCY ON DAILY BASIS.  Full Article

AmerisourceBergen Prices $750 Mln 3.45 Pct Senior Notes Due 2027
Thursday, 30 Nov 2017 

Nov 29 (Reuters) - AmerisourceBergen Corp ::AMERISOURCEBERGEN PRICES $750 MILLION 3.45% SENIOR NOTES DUE 2027 AND $500 MILLION 4.30% SENIOR NOTES DUE 2047.  Full Article

AmerisourceBergen to acquire H. D. Smith
Tuesday, 21 Nov 2017 

Nov 20 (Reuters) - AmerisourceBergen Corp ::AmerisourceBergen to acquire H. D. Smith.AmerisourceBergen Corp - deal for ‍$815 million in cash​.AmerisourceBergen Corp - ‍plans to fund acquisition through issuance of new long-term debt​.AmerisourceBergen Corp - ‍acquisition is expected to be slightly accretive to adjusted diluted EPS in fiscal year 2018​.AmerisourceBergen Corp - ‍acquisition expected to achieve full run-rate synergies, be about $0.15 accretive to adjusted EPS in FY 2020​.AmerisourceBergen Corp - ‍company now expects fiscal year 2018 adjusted operating income growth to be in range of 4 percent to 7 percent​.AmerisourceBergen Corp - now sees revenue growth to be in range of 8 percent to 11 percent​ for fiscal year 2018.AmerisourceBergen Corp - ‍reaffirming rest of previously announced fiscal 2018 financial guidance​.AmerisourceBergen - expects fiscal year 2018 pharmaceutical distribution services segment operating income growth in range of 4 percent to 7 percent​.  Full Article

AmerisourceBergen increases dividend 4 percent
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Amerisourcebergen Corp ::Increases dividend 4 percent.Increased company's quarterly dividend rate 4 percent to $0.38 per common share from $0.365 per common share​​.  Full Article

AmerisourceBergen, on conf call, says current trends indicate that generic buy side deflation rate has not worsened
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - AmerisourceBergen Corp ::AmerisourceBergen CEO, on conf call, says an aging U.S. patient population continues to "demand" the support of pharmaceutical intervention​.AmerisourceBergen CFO, on conf call - continue to experience headwind from lower Hepatitis C revenues this quarter, consistent with overall U.S. market trends.AmerisourceBergen CFO, on conf call - continue to see strong volume, revenue growth for oncology drugs due to expanded indications of overall market growth.AmerisourceBergen CFO, on conf call says our PharMEDium business experienced an increase in sequential shipping volumes in Q4.AmerisourceBergen CFO, on conf call, says current trends indicate that the generic buy side deflation rate has not worsened.AmerisourceBergen CFO, on conf call, says it is likely that only Q4 will have a full benefit of new pharmacies from Walgreens-Rite Aid deal.AmerisourceBergen CFO, on conf call, says transitioning customer contracts to more "balanced pricing" to offset lower contributions from generics.AmerisourceBergen, on conf call, when asked about Amazon's entry into drug supply chain, says "we haven't really counted Amazon at all yet as a threat".  Full Article

UPDATE 1-U.S. subpoenas AmerisourceBergen over opioid products

Aug 2 Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.